Clinical Trials on HER2-negative Breast Cancer in United Kingdom
Total 5781 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | HER2-positive Breast Cancer | Advanced Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterGilead SciencesRecruiting
-
University of Alabama at BirminghamNot yet recruitingTriple Negative Breast CancerUnited States
-
University of Illinois at ChicagoRecruitingTriple Negative Breast CancerUnited States
-
Baylor Research InstituteEli Lilly and CompanyCompletedTriple Negative Breast CancerUnited States
-
Joyce O'ShaughnessyTakedaCompletedTriple Negative Breast CancerUnited States
-
Indiana UniversityCompletedTriple Negative Breast CancerUnited States
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Brooklyn ImmunoTherapeutics, LLCActive, not recruitingBreast Cancer | Breast NeoplasmsUnited States
-
NYU Langone HealthNational Institutes of Health (NIH)TerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
ImmunityBio, Inc.Active, not recruiting
-
Washington University School of MedicineBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
Cedars-Sinai Medical CenterAstraZenecaWithdrawnBreast Cancer | Triple Negative Breast CancerUnited States
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterBellicum PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Relapse | Resistant CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene MutationUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast CancerUnited States
-
Leo W. Jenkins Cancer CenterTerminatedBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Susan G. Komen Breast Cancer...CompletedBreast CancerUnited States
-
SanofiBreast Cancer Research FoundationCompletedTriple Negative Breast CancerUnited States
-
University of Colorado, DenverCompletedMetastatic Breast Cancer | Solid TumorsUnited States
-
Seagen Inc.CompletedHER2 Positive Breast CancersUnited States, Canada
-
Hoffmann-La RocheTerminatedBreast CancerIsrael, Italy, Spain, United States, Belgium, Czechia, Australia, United Kingdom, Korea, Republic of, Romania, France, Taiwan, Latvia
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingTriple Negative Breast CancerUnited States
-
Stanford UniversityRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; ExelixisCompletedBreast CancerUnited States
-
Icahn School of Medicine at Mount SinaiChampions OncologyCompletedTriple Negative Breast CancerUnited States
-
Columbia UniversityAstellas Pharma Inc; Susan G. Komen Breast Cancer FoundationCompleted
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
National Cancer Institute (NCI)National Institutes of Health (NIH)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
Eileen ConnollyMerck Sharp & Dohme LLCRecruitingTriple Negative Breast CancerUnited States
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer...CompletedTriple Negative Breast CancerUnited States, China
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Carcinoma | Triple Negative Breast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Early Stage Triple-Negative Breast CarcinomaUnited States
-
Stephen ShiaoMerck Sharp & Dohme LLC; Incyte CorporationRecruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingTriple Negative Breast CancerUnited States
-
The University of Texas Health Science Center at...Completed
-
Washington University School of MedicineTerminatedBreast CancerUnited States
-
PfizerTerminatedNeoplasms | Triple-Negative Breast CancerUnited States
-
Providence Health & ServicesInhibrx, Inc.Not yet recruitingTriple Negative Breast CancerUnited States
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
University of GlasgowNHS Greater Glasgow and Clyde; Tenovus ScotlandRecruitingBreast Cancer | HER2-positive Breast Cancer | CardiotoxicityUnited Kingdom
-
Western Regional Medical CenterTerminated
-
Phoenix Molecular DesignsActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
Mylin A. Torres, MDPfizer; Genentech, Inc.; Emory UniversityTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
George Washington UniversityWithdrawnTriple Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedTriple-negative Breast CancerUnited States